Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Gastroenterology
Published in: BMC Gastroenterology 1/2020

Open Access 01-12-2020 | Portal Vein Thrombosis | Case report

Acute portal vein thrombosis secondary to COVID-19: a case report

Authors: Roham Borazjani, Seyed Reza Seraj, Mohammad Javad Fallahi, Zhila Rahmanian

Published in: BMC Gastroenterology | Issue 1/2020

Login to get access

Abstract

Background

COVID-19 pneumonia exhibits several extra-pulmonary complications.

Case presentation

A 23-year old, asthmatic male with coronavirus pneumonia developed with generalized, acute abdominal pain. Further evaluations revealed a mild ascites and portal vein thrombosis although the patient received proper anticoagulation therapy. Routine lab data regarding the secondary causes of portal vein thrombosis were normal.

Conclusion

We speculated that the underlying cause of portal vein thrombosis in our case was coronaviruses. Therefore, clinicians should always consider thrombosis and other hypercoagulable diseases in patients with COVID-19.
Literature
1.
Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Internal Med. 2020;35:1545–9.CrossRef
2.
Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–50.CrossRef
3.
Basta M. Intravenous immunoglobulin-related thromboembolic events—an accusation that proves the opposite. Clin Exp Immunol. 2014;178:153–5.CrossRef
4.
5.
6.
Bozzani A, Arici V, Franciscone MM, Danesino V, Cascina A, Ticozzelli G, et al. Severe acute respiratory syndrome coronavirus 2 infection and the upper limb deep vein thrombosis risk. Ann Vasc Surg. 2020;66:11–3.CrossRef
7.
Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421–4.CrossRef
8.
Dmytriw AA, Vulkanov V, Agarwal S, Khaneja A, Turkel-Parella D, Liff J, et al. Etiologic Subtypes of Ischemic Stroke in SARS-COV-2 Virus patients. Front Neurol. 2020;11(1004).
9.
de Barry O, Mekki A, Diffre C, Seror M, El Hajjam M, Carlier R-Y. Arterial and venous abdominal thrombosis in a 79-year-old woman with COVID-19 pneumonia. Radiol Case Rep. 2020;15(7):1054–7.CrossRef
10.
La Mura V, Artoni A, Martinelli I, Rossio R, Gualtierotti R, Ghigliazza G, et al. Acute portal vein thrombosis in SARS-CoV-2 infection: a case report. Off J Am Coll Gastroenterol. 2020;115(7):1140–2.
11.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.CrossRef
12.
13.
Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020;18:1559–61.CrossRef
14.
Sharma A, Garcia G, Arumugaswami V, Svendsen CN. Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection. Cell Rep Med. 2020;1(4):100052.
15.
Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis. 2020;50(1):54–67.CrossRef
16.
Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis. 2020;18–20
Metadata
Title
Acute portal vein thrombosis secondary to COVID-19: a case report
Authors
Roham Borazjani
Seyed Reza Seraj
Mohammad Javad Fallahi
Zhila Rahmanian
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2020
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-020-01518-2

Other articles of this Issue 1/2020

BMC Gastroenterology 1/2020 Go to the issue

Research article

The association of genetic polymorphisms with nonalcoholic fatty liver disease in a longitudinal study

Research article

Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study

Case report

Concurrent cerebral arterial and venous sinus thrombosis revealing celiac disease- a case report and literature review

Research article

Increased expression of hypoxia inducible factor-1 alpha and vascular endothelial growth factor is associated with diabetic gastroparesis

Case report

Juvenile polyposis syndrome might be misdiagnosed as familial adenomatous polyposis: a case report and literature review

Case report

A combination of single-balloon enteroscopy-assisted laparoscopy and endoscopic mucosal resection for treating gastrointestinal venous malformations in blue rubber bleb nevus syndrome: a case report
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits